Depression Care360

Veronica Ridpath, DO, Psych Congress Elevate faculty member, discusses how evolving understanding of the biological pathways involved in depression is changing the landscape of treatment approaches.

An insightful discussion between Craig Chepke, MD, DFAPA, and Kristian Dambrino, DNP, PMHNP-BC.

In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in depression treatment.

In this video, Bin Huang, DrPH, discusses his team's study, which used data from the Kentucky Cancer Registry to assess the influence of depression on breast cancer treatment and survival, what he found...

In part 2 of this interview, Charles Raison, MD, examines what remaining questions he has about hyperthermia use in depression treatment.

Charles Raison, MD, describes the results of his recent study on using hyperthermia in depression treatment.

In this video, Nurse Penn and Dr Jain examine hyperbolic tapering, using liquid medications, the half-life and pharmacokinetics of fluoxetine, discussing processes with patients, and more.

Ahmed Baig, MD, Chief Medical Officer at Midwest Research Group, discusses MDD and TRD treatment.